The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.
Principal Investigator(s)
Bunnik, Evelien M
Funded by
NIH-ALLERGY & INFECTIOUS DISEASES
Malaria remains a significant global health problem that would greatly benefit from the development of avaccine. Protection against clinical disease could be achieved by eliciting a protective immune responseagainst the blood stage of the malaria parasite. However, only a very limited number of vaccine candidates arecurrently being studied. One approach to uncover novel potential vaccine targets is to analyze protective anti-malaria immunity in response to natural infection. Natural Plasmodium falciparum infections induce antibodyresponses that target the blood stage of this parasite.